High-throughput screening for norepinephrine transporter inhibitors using the FLIPRTetra.

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Monoamine transporters are crucial for neurotransmitter regulation and significant pharmaceutical drug targets.
• Current high-throughput screening methods for inhibitors are often limited by labor-intensive functional uptake assays using radioactive substrates.
• Radioligand binding assays are commonly used but do not always reflect functional activity.

Purpose of the Study:

• To develop a novel, high-throughput functional screening assay for norepinephrine transporter inhibitors.
• To establish a method that overcomes the limitations of radioactive assays for screening transporter inhibitors.
• To enable efficient identification of potential drug candidates targeting the norepinephrine transporter.

Main Methods:

• Development of a 384-well, high-throughput functional screening assay.
• Utilized the FLIPR Tetra system for assay detection.
• Employed a fluorescent substrate, 4-(4-dimethylaminostyryl)-N-methyl-pyridinium (ASP(+)).

Main Results:

• Successfully developed a robust 384-well assay for functional screening of norepinephrine transporter inhibitors.
• The assay demonstrated high-throughput capability, suitable for screening large compound libraries.
• The use of a fluorescent substrate (ASP(+)) provided a viable alternative to radioactive assays.

Conclusions:

• The developed assay provides an efficient and high-throughput method for identifying norepinephrine transporter inhibitors.
• This functional assay offers advantages over traditional radioligand binding assays for drug discovery.
• The new assay facilitates the discovery of novel therapeutics targeting monoamine transporters.